Clinical Trials Logo
  1. Home
  2. Intracranial Hemorrhages
  3. NCT05159219

Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage — CoVasc-ICH  

Intracranial Hemorrhages Clinical Trial

Official title:
A Vanguard, Double-blind, Randomized, Placebo-controlled, Phase 2 Pilot Study to Investigate Prevention of Cardiovascular Events With Oral Colchicine 0.5mg Once Daily Compared With Placebo in Participants With Spontaneous ICH and Established, or Risk Factors for, Atherosclerosis

Clinical Trial Summary

The overall goal is to establish the safety and efficacy of colchicine in ICH patients for the prevention of major cardiovascular events and brain injury. Colchicine for the prevention of vascular events after an acute intracerebral hemorrhage (CoVasc-ICH) is a vanguard pilot trial designed to obtain the factual feasibility prerequisites essential for the planning, design, funding and execution of a subsequent phase III trial.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05159219
Study type Interventional
Source Population Health Research Institute
Contact
Status Active, not recruiting
Phase Phase 2
Start date August 4, 2022
Completion date February 2025
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03969732 - Multimodal Biomarkers for Diagnosis and Prognosis in CAA Phase 3
Recruiting NCT05968053 - Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
Recruiting NCT02962349 - TRansfusion Strategies in Acute Brain INjured Patients N/A
Recruiting NCT03950076 - EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF) Phase 4
Completed NCT03542656 - Application of Amyloid PET in Cerebral Amyloid Angiopathy Phase 3
Active, not recruiting NCT05626504 - Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms
Recruiting NCT03495206 - Safety, Tolerability and Pharmacokinetics of Y-2(Edaravone And Borneol) Sublingual Tablet Phase 1
Not yet recruiting NCT04229758 - Restarting Anticoagulation After Traumatic Intracranial Hemorrhage Phase 3
Recruiting NCT02135783 - Decompressive Craniectomy Combined With Hematoma Removal to Treat ICH N/A
Enrolling by invitation NCT02050971 - Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates Phase 1
Completed NCT01193270 - Vitamin E for Extremely Preterm Infants Phase 1
Completed NCT02881957 - Hypovitaminosis D in Neurocritical Patients Phase 2/Phase 3
Completed NCT03364634 - Intracranial Pressure After Decompressive Craniectomy N/A
Completed NCT00226096 - Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage N/A
Recruiting NCT06081283 - Antiseizure Medication in Seizure Networks at Early Acute Brain Injury Phase 4
Recruiting NCT04459806 - Intracranial PrEssure Time dOse (ImPETO)
Recruiting NCT05874050 - Arterial Pressure and Surgical Hemostasis in Elective Neurosurgery.
Not yet recruiting NCT05138341 - Minimal Invasive Surgical Intracerebral Hemorrhage Removal N/A
Terminated NCT03660618 - LSFG-SKIN, Laser Speckle Flowgraphy N/A
Recruiting NCT06370520 - Screening Emotions in Adolescents at the Hospital for mTBI